FRM-0334, also called EPV-0334, promotes histone 2A, 3, and 4 acetylation in the brain and exerts a potential neuroprotective role by restoring the levels of the growth factor progranulin, which results in a significant improvement of cognitive performance in mice and rat models of frontotemporal dementia [171]. This evidence concerns the gene GRN and frontotemporal dementia.